vs
Side-by-side financial comparison of PILGRIMS PRIDE CORP (PPC) and TEVA PHARMACEUTICAL INDUSTRIES LTD (TEVA). Click either name above to swap in a different company.
PILGRIMS PRIDE CORP is the larger business by last-quarter revenue ($4.5B vs $4.0B, roughly 1.1× TEVA PHARMACEUTICAL INDUSTRIES LTD). TEVA PHARMACEUTICAL INDUSTRIES LTD runs the higher net margin — 9.3% vs 2.2%, a 7.0% gap on every dollar of revenue. On growth, TEVA PHARMACEUTICAL INDUSTRIES LTD posted the faster year-over-year revenue change (100.0% vs 1.6%). Over the past eight quarters, PILGRIMS PRIDE CORP's revenue compounded faster (-0.3% CAGR vs -2.2%).
Pilgrim's Pride Corporation is an American, multi-national food company, currently one of the largest chicken producers in the United States and Puerto Rico and the second-largest chicken producer in Mexico. It exited bankruptcy in December 2009 and relocated its U.S. headquarters to Greeley, Colorado, in 2011. It is majority-owned by JBS S.A. Pilgrim's Pride purchased Gold'n Plump for $350 million in late November 2016.
Teva Pharmaceutical Industries Ltd. is an Israeli multinational pharmaceutical company. Teva specializes primarily in generic drugs, but other business interests include branded-drugs, active pharmaceutical ingredients (APIs) and, to a lesser extent, contract manufacturing services and an out-licensing platform.
PPC vs TEVA — Head-to-Head
Income Statement — Q1 FY2026 vs Q1 FY2026
| Metric | | |
|---|---|---|
| Revenue | $4.5B | $4.0B |
| Net Profit | $101.5M | $369.0M |
| Gross Margin | 7.6% | 26.1% |
| Operating Margin | 3.6% | — |
| Net Margin | 2.2% | 9.3% |
| Revenue YoY | 1.6% | 100.0% |
| Net Profit YoY | — | 67.7% |
| EPS (diluted) | $0.43 | $-0.66 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q1 26 | $4.5B | $4.0B | ||
| Q4 25 | $4.5B | $4.7B | ||
| Q3 25 | $4.8B | $4.5B | ||
| Q2 25 | $4.8B | $4.2B | ||
| Q1 25 | $4.5B | $3.9B | ||
| Q4 24 | $4.4B | $4.2B | ||
| Q3 24 | $4.6B | $4.3B | ||
| Q2 24 | $4.6B | $4.2B |
| Q1 26 | $101.5M | $369.0M | ||
| Q4 25 | $88.0M | $481.0M | ||
| Q3 25 | $342.8M | $433.0M | ||
| Q2 25 | $355.5M | $282.0M | ||
| Q1 25 | $296.0M | $214.0M | ||
| Q4 24 | $235.9M | $-217.0M | ||
| Q3 24 | $349.9M | $-437.0M | ||
| Q2 24 | $326.3M | $-846.0M |
| Q1 26 | 7.6% | 26.1% | ||
| Q4 25 | 9.5% | 56.4% | ||
| Q3 25 | 13.9% | 51.4% | ||
| Q2 25 | 15.0% | 50.3% | ||
| Q1 25 | 12.4% | 48.2% | ||
| Q4 24 | 12.7% | 50.2% | ||
| Q3 24 | 14.9% | 49.6% | ||
| Q2 24 | 15.2% | 48.6% |
| Q1 26 | 3.6% | — | ||
| Q4 25 | 4.5% | 6.4% | ||
| Q3 25 | 10.4% | 19.7% | ||
| Q2 25 | 10.8% | 10.9% | ||
| Q1 25 | 9.1% | 13.3% | ||
| Q4 24 | 7.0% | -0.7% | ||
| Q3 24 | 11.1% | -1.2% | ||
| Q2 24 | 9.7% | -0.1% |
| Q1 26 | 2.2% | 9.3% | ||
| Q4 25 | 1.9% | 10.2% | ||
| Q3 25 | 7.2% | 9.7% | ||
| Q2 25 | 7.5% | 6.8% | ||
| Q1 25 | 6.6% | 5.5% | ||
| Q4 24 | 5.4% | -5.1% | ||
| Q3 24 | 7.6% | -10.1% | ||
| Q2 24 | 7.2% | -20.3% |
| Q1 26 | $0.43 | $-0.66 | ||
| Q4 25 | $0.37 | $0.42 | ||
| Q3 25 | $1.44 | $0.37 | ||
| Q2 25 | $1.49 | $0.24 | ||
| Q1 25 | $1.24 | $0.18 | ||
| Q4 24 | $1.00 | $-0.19 | ||
| Q3 24 | $1.47 | $-0.39 | ||
| Q2 24 | $1.37 | $-0.75 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $542.4M | $3.7B |
| Total DebtLower is stronger | $3.1B | $2.6B |
| Stockholders' EquityBook value | $3.7B | $8.2B |
| Total Assets | $10.2B | $40.0B |
| Debt / EquityLower = less leverage | 0.83× | 0.32× |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | $542.4M | $3.7B | ||
| Q4 25 | $640.2M | $3.6B | ||
| Q3 25 | $612.6M | $2.2B | ||
| Q2 25 | $849.0M | $2.2B | ||
| Q1 25 | $2.1B | $1.7B | ||
| Q4 24 | $2.0B | $3.3B | ||
| Q3 24 | $1.9B | $3.3B | ||
| Q2 24 | $1.3B | $2.3B |
| Q1 26 | $3.1B | $2.6B | ||
| Q4 25 | $3.1B | — | ||
| Q3 25 | $3.1B | — | ||
| Q2 25 | $3.1B | — | ||
| Q1 25 | $3.2B | — | ||
| Q4 24 | $3.2B | — | ||
| Q3 24 | $3.2B | — | ||
| Q2 24 | $3.2B | — |
| Q1 26 | $3.7B | $8.2B | ||
| Q4 25 | $3.7B | $7.9B | ||
| Q3 25 | $3.5B | $7.3B | ||
| Q2 25 | $3.7B | $6.8B | ||
| Q1 25 | $3.1B | $6.3B | ||
| Q4 24 | $4.2B | $5.4B | ||
| Q3 24 | $4.2B | $6.1B | ||
| Q2 24 | $3.7B | $6.4B |
| Q1 26 | $10.2B | $40.0B | ||
| Q4 25 | $10.3B | $40.7B | ||
| Q3 25 | $10.0B | $39.9B | ||
| Q2 25 | $10.1B | $40.1B | ||
| Q1 25 | $11.0B | $38.4B | ||
| Q4 24 | $10.7B | $39.3B | ||
| Q3 24 | $10.7B | $41.8B | ||
| Q2 24 | $10.1B | $41.3B |
| Q1 26 | 0.83× | 0.32× | ||
| Q4 25 | 0.84× | — | ||
| Q3 25 | 0.87× | — | ||
| Q2 25 | 0.83× | — | ||
| Q1 25 | 1.02× | — | ||
| Q4 24 | 0.76× | — | ||
| Q3 24 | 0.76× | — | ||
| Q2 24 | 0.85× | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | — | — |
| Free Cash FlowOCF − Capex | — | $188.0M |
| FCF MarginFCF / Revenue | — | 4.7% |
| Capex IntensityCapex / Revenue | — | — |
| Cash ConversionOCF / Net Profit | — | — |
| TTM Free Cash FlowTrailing 4 quarters | — | $1.6B |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | — | — | ||
| Q4 25 | $291.2M | $1.2B | ||
| Q3 25 | $458.3M | $369.0M | ||
| Q2 25 | $495.2M | $227.0M | ||
| Q1 25 | $126.9M | $-105.0M | ||
| Q4 24 | $349.3M | $575.0M | ||
| Q3 24 | $651.1M | $693.0M | ||
| Q2 24 | $718.6M | $103.0M |
| Q1 26 | — | $188.0M | ||
| Q4 25 | $10.0M | $1.0B | ||
| Q3 25 | $275.9M | $233.0M | ||
| Q2 25 | $339.1M | $131.0M | ||
| Q1 25 | $28.1M | $-232.0M | ||
| Q4 24 | $176.6M | $446.0M | ||
| Q3 24 | $565.3M | $545.0M | ||
| Q2 24 | $617.7M | $6.0M |
| Q1 26 | — | 4.7% | ||
| Q4 25 | 0.2% | 21.6% | ||
| Q3 25 | 5.8% | 5.2% | ||
| Q2 25 | 7.1% | 3.1% | ||
| Q1 25 | 0.6% | -6.0% | ||
| Q4 24 | 4.0% | 10.5% | ||
| Q3 24 | 12.3% | 12.6% | ||
| Q2 24 | 13.5% | 0.1% |
| Q1 26 | — | — | ||
| Q4 25 | 6.2% | 3.0% | ||
| Q3 25 | 3.8% | 3.0% | ||
| Q2 25 | 3.3% | 2.3% | ||
| Q1 25 | 2.2% | 3.3% | ||
| Q4 24 | 4.0% | 3.1% | ||
| Q3 24 | 1.9% | 3.4% | ||
| Q2 24 | 2.2% | 2.3% |
| Q1 26 | — | — | ||
| Q4 25 | 3.31× | 2.41× | ||
| Q3 25 | 1.34× | 0.85× | ||
| Q2 25 | 1.39× | 0.80× | ||
| Q1 25 | 0.43× | -0.49× | ||
| Q4 24 | 1.48× | — | ||
| Q3 24 | 1.86× | — | ||
| Q2 24 | 2.20× | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
PPC
| U.S | $2.6B | 58% |
| Europe | $1.4B | 30% |
| Mexico | $545.5M | 12% |
TEVA
Segment breakdown not available.
